Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.970
+0.150 (8.24%)
At close: Mar 9, 2026, 4:00 PM EDT
1.990
+0.020 (1.02%)
After-hours: Mar 9, 2026, 5:10 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $190.38 million as of March 9, 2026. Its market cap has increased by 49.10% in one year.
Market Cap
190.38M
Enterprise Value
74.27M
1-Year Change
49.10%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $190.38M, a decrease of -78.57%. That is a compound annual growth rate of -28.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 175.88M | 18.35% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 202.94M |
| Compugen | 201.87M |
| ProQR Therapeutics | 198.05M |
| NeOnc Technologies Holdings | 191.80M |
| Whitehawk Therapeutics | 190.87M |
| Acumen Pharmaceuticals | 188.99M |
| Nkarta | 188.94M |
| Molecular Partners AG | 187.40M |